Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Conditions: Corona Virus Infection; Covid19; SARS-CoV Infection Interventions: Drug: Placebo administration; Diagnostic Test: Confirm SARS-CoV-2 infection; Procedure: Physical Examination; Procedure: Vital Signs; Diagnostic Test: Hematology blood test; Diagnostic Test: Biochemistry blood test; Other: NEWS score; Diagnostic Test: P K test; Diagnostic Test: blood test for inflammatory markers; Diagnostic Test: D-dimer test; Other: VAS scale; Diagnostic Test: Urine pregnancy test for women of childbearing potential; Procedure: ECG; Other: COVID-19-Impact on Quality of Life Questionnaire; Drug: Cimetr A-1; Drug: CimetrA-2 Sponsor: MGC Pharmaceuticals d.o.o Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials